Connect with us

Hi, what are you looking for?


UnitedHealth stock slides despite raised guidance: buy the dip?

UnitedHealth Group Inc (NYSE: UNH), on Friday, reported market-beating results for its fiscal first quarter and raised its guidance for the full year. Shares still ended about 3.0% down.

Why is UnitedHealth stock down then?

The stock slipped primarily because the healthcare behemoth said lower-than-expected Medical Advantage rates for 2024 could be a nuisance.

Based on the expressed concern, Shelby McFaddin of Motley Fool Asset Management said, at best, she’d rate the UnitedHealth stock only at “hold” for now.

Medical reimbursement rates affect the entire industry. UNH can’t do anything to control the government, those decisions. So, I’ll hold and see if they can show me that they’ll be the best in class while everyone is dealing with this.

UNH fundamentals continue to be strong

“MCR” – the medical care ratio climbed to 82.2% in the recently concluded quarter, a 220-bps increase versus a 250-bps increase expected. Remember that lower MCR suggests greater profitability for an insurance business.

Operating cost ratio also climbed a more than expected 60 basis points to 14.8%. Still, McFaddin agreed on CNBC’s “Power Lunch”:

The fundamentals, otherwise, look really strong. The business is really strong. They’re very competitive. They had a really great quarter, beat and raise.

It’s also noteworthy that Wall Street currently has a consensus “buy” rating on the UnitedHealth stock.

UnitedHealth Q1 earnings and future guidance

Earned $5.61 billion versus the year-ago $5.03 billion

Per-share earnings also climbed from $5.27 to $5.95

Adjusted EPS printed at $6.26 as per the press release

Revenue jumped 14.7% year-on-year to $91.93 billion

Consensus was $6.16 a share on $89.7 billion revenue

Optum revenue climbed a whopping 24.9% in Q1

The healthcare stock may also be down because the raised guidance still came in shy of Street estimates. For the full year, the Minnetonka-headquartered firm now forecasts $24.50 a share to $25 a share of adjusted earnings. In comparison, analysts were at $24.93 per share.

For the year, UnitedHealth shares are down just over 1.0% at writing.

The post UnitedHealth stock slides despite raised guidance: buy the dip? appeared first on Invezz.

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Latest News

    Rep. Jennifer Wexton (D-Va.) announced on Tuesday that she has been diagnosed with Parkinson’s Disease. “If there’s one thing that Democrats and Republicans can...

    Latest News

    After Dianne Feinstein announced she’d contracted the shingles in early March, her staff said she planned to return to the Senate within a matter...


    A U.S. District Court judge has ruled that Elizabeth Holmes, founder and CEO of the disgraced blood-testing company Theranos, cannot remain free on bail...

    Latest News

    SEOUL, South Korea — When a group of American lawmakers arrived in South Korea for meetings with government and military officials, President Yoon Suk-yeol...

    Disclaimer:, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2022 All Rights Reserved.